Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jacob Painter

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPharmacy Practice, College of Pharmacy
DivisionPharmacy Practice
Address6257 ED III College of Public Health
220 UAMS Campus Dr.
Mail Slot # 522
Little Rock AR 72205
Phone501-686-7123
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUniversity of Arkansas for Medical Sciences
    DepartmentPsychiatry, College of Medicine
    DivisionCenter for Health Service Research


    Collapse Research 
    Collapse research activities and funding
    R01NR019487     (MCELFISH, PEARL A)Jul 1, 2023 - Jun 30, 2025
    NIH/Nat. Inst. of Nursing Research
    Home Food Delivery for Diabetes Management in Patients of Rural Clinics - Continuation
    Role: Principal Investigator
    R01MD016992     (CARPENTER, DELESHA MILLER)Sep 22, 2022 - May 31, 2025
    NIH
    Addressing COVID 19 Vaccine Hesitancy in Rural Community Pharmacies Reducing Disparities Through an Implementation Science Approach
    Role: Principal Investigator
    IK2HX003358     (HAYES, COREY)Apr 1, 2022 - Mar 31, 2027
    VA HSR&D
    Data to Clinical Action: Using Predictive Analytics to Improve Care of Veterans with Opioid Use Disorder
    Role: Co-Investigator
    CON     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator
    CON-80003534(GR114526)     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator
    CON-80004654(GR121975) Am 2     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator
    RM1DA055310     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator
    R37CA252113     (SWINDLE, TAREN)Sep 1, 2021 - Aug 31, 2026
    NIH
    Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
    Role: Co-Investigator
    UG3AT009765     (PAINTER, JACOB T)Sep 20, 2017 - Dec 31, 2019
    NIH/National Institutes of Health - Pass Through: Northern California Institute for Research and Education
    Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Functioning, and Quality of Life in Veterans
    Role: Principal Investigator
    P20GM109096     (WEBER, JUDITH LYNNE)Aug 1, 2016 - Jul 31, 2026
    NIH
    Center for Childhood Obesity Prevention
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Cetto AV, Chandler MW, Shah NK, Luciani LL, Painter J. Evaluating the Impact of Buprenorphine on Depressive Symptoms Among Veterans with Chronic Pain. J Pain Palliat Care Pharmacother. 2024 Nov 22; 1-6. PMID: 39576726.
      View in: PubMed
    2. Painter JT, Pyne J, Curran G, Raciborski RA, Russell S, Fortney J, Gifford AL, Ohl M, Woodward EN. Implementation of collaborative care for depression in VA HIV clinics: Translating?Initiatives for Depression into Effective Solutions (HITIDES): protocol for a cluster-randomized type 3 hybrid effectiveness-implementation trial. Implement Sci Commun. 2024 Sep 16; 5(1):99. PMID: 39285308.
      View in: PubMed
    3. Murphy PZ, Bramwell-Shittu A, Boehmer K, Painter J, Mahashabde R. Assessment of Metformin Intolerance: A Retrospective Chart Review. Innov Pharm. 2024; 15(3). PMID: 39483503.
      View in: PubMed
    4. Painter JT, McLeroy-Charles K, Moore H, Harrington S, Dayer LE. Outpatient Patient Controlled Analgesia (PCA) for the Palliative Care Patient. J Pain Palliat Care Pharmacother. 2024 Aug 05; 1-6. PMID: 39102589.
      View in: PubMed
    5. Mahashabde RV, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases. Transl Lung Cancer Res. 2024 Jul 30; 13(7):1620-1634. PMID: 39118898.
      View in: PubMed
    6. Fortney JC, Kaysen DL, Engel CC, Cerimele JM, Nolan JP, Chase E, Blanchard BE, Hauge S, Bechtel J, Moore DL, Taylor A, Acierno R, Nagel N, Sripada RK, Painter JT, DeBeer BB, Bluett E, Teo AR, Morland LA, Heagerty PJ. Sequenced Treatment Effectiveness for Posttraumatic Stress (STEPS) Trial: A protocol for a pragmatic comparative effectiveness trial with baseline results. Contemp Clin Trials. 2024 Sep; 144:107606. PMID: 38866094.
      View in: PubMed
    7. Painter JT, Peng C, Burlette M, Clement C, Luciani L, Azhar G, Dayer L. The Effect of Concurrent Use of Opioids and Gabapentin on Fall Risk in Older Adults. J Pain Palliat Care Pharmacother. 2024 Jun 10; 1-7. PMID: 38857121.
      View in: PubMed
    8. Matthieu MM, Taylor LD, Adkins DA, Williams JS, Hu B, Oliver CM, McCullough JA, Mallory MJ, Smith ID, Painter JT, Ounpraseuth ST, Garner KK. Adopting the RE-AIM analytic framework for rural program evaluation: experiences from the Advance Care Planning via Group Visits (ACP-GV) national evaluation. Front Health Serv. 2024; 4:1210166. PMID: 38590731.
      View in: PubMed
    9. Short E, Selig JP, Felix HC, Painter J, McElfish PA, Rowland B, Ammerman AS, Bounds K, Henske J, Hudson JS, Li J, Young SG, Long CR. Healthy food delivery for type 2 diabetes management in rural clinics' patients: A comparative effectiveness randomized controlled trial protocol. Contemp Clin Trials. 2024 05; 140:107491. PMID: 38458560.
      View in: PubMed
    10. Landes SJ, Matarazzo BB, Pitcock JA, Drummond KL, Smith BN, Kirchner JE, Clark KA, Gerard GR, Jankovsky MC, Brenner LA, Reger MA, Eagan AE, Raciborski R, Painter J, Townsend JC, Jegley SM, Singh RS, Trafton JA, McCarthy JF, Katz IR. Impact of Implementation Facilitation on the REACH VET Clinical Program for Veterans at Risk for Suicide. Psychiatr Serv. 2024 Aug 01; 75(8):726-732. PMID: 38444365.
      View in: PubMed
    11. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations. Pain Med. 2024 Mar 01; 25(3):173-186. PMID: 38243702.
      View in: PubMed
    12. Vordenberg SE, Fusco NM, Ward KE, Darley A, Brady JH, Culhane NS, Habib MJ, Hernandez E, Moye PM, Munusamy S, Painter JT, Pope N, Stevenson TL, Vanderboll K, Chase PA, Matsumoto RR. An Integrative Review of Micro-Credentials and Digital Badges for Pharmacy Educators. Am J Pharm Educ. 2024 Mar; 88(3):100660. PMID: 38272238.
      View in: PubMed
    13. Curran G, Mosley C, Gamble A, Painter J, Ounpraseuth S, Brewer NT, Teeter B, Smith M, Halladay J, Hughes T, Shepherd JG, Hastings T, Simpson K, Carpenter D. Addressing COVID-19 vaccine hesitancy in rural community pharmacies: a protocol for a stepped wedge randomized clinical trial. Implement Sci. 2023 Dec 18; 18(1):72. PMID: 38110979.
      View in: PubMed
    14. Painter JT, Raciborski RA, Matthieu MM, Oliver CM, Adkins DA, Garner KK. Engaging stakeholders to retrospectively discern implementation strategies to support program evaluation: Proposed method and case study. Eval Program Plann. 2024 Apr; 103:102398. PMID: 38183893.
      View in: PubMed
    15. Dhuliawala S, Payakachat N, Painter JT, Swindle T, Li C. Food Insecurity and Health Outcomes of Children With Intellectual and Developmental Disabilities in the United States. Am J Intellect Dev Disabil. 2023 11 01; 128(6):462-480. PMID: 37875275.
      View in: PubMed
    16. ElHassan NO, Crawford B, Alamarat Z, Painter JT. Clinical Review of Risk of Nephrotoxicity with Acyclovir Use for Treatment of Herpes Simplex Virus Infections in Neonates and Children. J Pediatr Pharmacol Ther. 2023; 28(6):490-503. PMID: 38130345.
      View in: PubMed
    17. Mahashabde R, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain Metastases. JCO Oncol Pract. 2023 11; 19(11):1009-1019. PMID: 37729600.
      View in: PubMed
    18. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clin Breast Cancer. 2023 08; 23(6):598-619. PMID: 37328334.
      View in: PubMed
    19. Shah NK, Chandler MW, Cetto AV, Luciani LL, Painter J, Bailey D. Retrospective Cohort Study of Safety Outcomes Associated with Opioid Rotations to Buprenorphine. J Pain Palliat Care Pharmacother. 2023 Sep; 37(3):234-245. PMID: 37097772.
      View in: PubMed
    20. Matthieu MM, Ounpraseuth ST, Williams JS, Hu B, Adkins DA, Taylor LD, Oliver CM, Smith RM, Painter JT, McCullough JA, Garner KK. "Advancing" Advance Care Planning to Veterans in the Veterans Health Administration. Mil Med. 2023 03 20; 188(3-4):786-791. PMID: 35801841.
      View in: PubMed
    21. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 03 01; 39(3):107-118. PMID: 36728675.
      View in: PubMed
    22. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. J Cancer Surviv. 2024 Jun; 18(3):917-927. PMID: 36753003.
      View in: PubMed
    23. Raciborski RA, Woodward EN, Painter JT. Economic analyses of behavioral health intervention implementation: Perspective on stakeholder engagement. Front Psychiatry. 2022; 13:1031325. PMID: 36620658.
      View in: PubMed
    24. Dayer LE, Wagner R, King D, Lakkad M, Wilson LA, Montgomery C, Painter JT. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. J Pain Palliat Care Pharmacother. 2022 Dec; 36(4):223-227. PMID: 36688614.
      View in: PubMed
    25. Boehmer K, Lakkad M, Johnson C, Painter JT. Depression and diabetes distress in patients with diabetes. Prim Care Diabetes. 2023 02; 17(1):105-108. PMID: 36424309.
      View in: PubMed
    26. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data. J Cancer Surviv. 2023 08; 17(4):917-950. PMID: 36369622.
      View in: PubMed
    27. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957. PMID: 36000252.
      View in: PubMed
    28. Swindle T, Rutledge JM, Selig JP, Painter J, Zhang D, Martin J, Johnson SL, Whiteside-Mansell L, Almirall D, Barnett-McElwee T, Curran GM. Obesity prevention practices in early care and education settings: an adaptive implementation trial. Implement Sci. 2022 03 18; 17(1):25. PMID: 35303894.
      View in: PubMed
    29. Dare RK, Lusardi K, Pearson C, McCain KD, Daniels KB, Van S, Rico JC, Painter J, Lakkad M, Rosenbaum ER, Bariola JR. Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients. Clin Infect Dis. 2021 12 06; 73(11):e4616-e4626. PMID: 32463864.
      View in: PubMed
    30. Landes SJ, Jegley SM, Kirchner JE, Areno JP, Pitcock JA, Abraham TH, McBain SA, Singh RS, Bollinger MJ, Painter J, Woods JA, Curtis ND, Jones DE, Matarazzo BB, Reger MA, Comtois KA. Adapting Caring Contacts for Veterans in a Department of Veterans Affairs Emergency Department: Results From a Type 2 Hybrid Effectiveness-Implementation Pilot Study. Front Psychiatry. 2021; 12:746805. PMID: 34721114.
      View in: PubMed
    31. Callaway K, Lakkad M, Painter JT, Dayer L, Oswalt AK. The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients. J Pharm Pract. 2023 Apr; 36(2):276-280. PMID: 34376087.
      View in: PubMed
    32. Chopra D, Li C, Painter JT, Bona JP, Nookaew I, Martin BC. Characteristics and Network Influence of Providers Involved in the Treatment of Patients With Chronic Back, Neck or Joint Pain in Arkansas. J Pain. 2021 12; 22(12):1681-1695. PMID: 34174385.
      View in: PubMed
    33. Muzzio K, Chandler M, Painter JT, Dragic L. Characterizing Patients after Opioid Taper in a VA Medical Center. J Pain Palliat Care Pharmacother. 2021 Jun; 35(2):84-90. PMID: 33956566.
      View in: PubMed
    34. Klucher JM, Davis K, Lakkad M, Painter JT, Dare RK. Risk factors and clinical outcomes associated with blood culture contamination. Infect Control Hosp Epidemiol. 2022 03; 43(3):291-297. PMID: 33896442.
      View in: PubMed
    35. Dragic L, Webb T, Chandler M, Harrington SB, McDade E, Dayer L, Painter JT. Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients. J Pain Palliat Care Pharmacother. 2020 Dec; 34(4):192-196. PMID: 32924715.
      View in: PubMed
    36. Matthieu MM, Ounpraseuth ST, Painter J, Waliski A, Williams JS, Hu B, Smith R, Garner KK. Evaluation of the national implementation of the VA Diffusion of Excellence Initiative on Advance Care Planning via Group Visits: protocol for a quality improvement evaluation. Implement Sci Commun. 2020; 1:19. PMID: 32885180.
      View in: PubMed
    37. Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):244-247. PMID: 31843373.
      View in: PubMed
    38. Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing. J Emerg Med. 2019 11; 57(5):597-602. PMID: 31594747.
      View in: PubMed
    39. Stolarz AJ, Lakkad M, Klimberg VS, Painter JT. Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2019 Nov; 28(11):1809-1815. PMID: 31399477.
      View in: PubMed
    40. Chopra DA, Shah AB, Vadhariya AH, Painter JT. The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy. Epilepsy Behav. 2019 08; 97:169-173. PMID: 31252274.
      View in: PubMed
    41. Hammond DA, Painter JT, Meena N. Incidence of Clinically Significant Hypotension Stratified by Vasopressin Duration. J Intensive Care Med. 2019 Jan; 34(1):77-78. PMID: 30798676.
      View in: PubMed
    42. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Subst Use Misuse. 2019; 54(2):331-339. PMID: 30572776.
      View in: PubMed
    43. Midboe AM, Martino S, Krein SL, Frank JW, Painter JT, Chandler M, Schroeder A, Fenton BT, Troszak L, Erhardt T, Kerns RD, Becker WC. Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol. Implement Sci. 2018 11 29; 13(1):145. PMID: 30486877.
      View in: PubMed
    44. Hammond DA, Rowe JM, Wiley TL, Painter JT. Evaluation of an elective course for preparing students to pursue postgraduate residency training. Curr Pharm Teach Learn. 2018 09; 10(9):1264-1271. PMID: 30497630.
      View in: PubMed
    45. Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, Kakkera K, Chopra D, Meena N. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock. Pharmacotherapy. 2018 05; 38(5):531-538. PMID: 29600824.
      View in: PubMed
    46. Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ. Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury. Pain Med. 2018 04 01; 19(4):774-787. PMID: 29036680.
      View in: PubMed
    47. Becker WC, Mattocks KM, Frank JW, Bair MJ, Jankowski RL, Kerns RD, Painter JT, Fenton BT, Midboe AM, Martino S. Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management. Addict Behav. 2018 11; 86:138-145. PMID: 29576479.
      View in: PubMed
    48. Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 03; 159(3):451-459. PMID: 29189516.
      View in: PubMed
    49. Painter JT, Gressler L, Kathe N, Slabaugh SL, Blumenschein K. Consumer willingness to pay for pharmacy services: An updated review of the literature. Res Social Adm Pharm. 2018 12; 14(12):1091-1105. PMID: 29398405.
      View in: PubMed
    50. Hammond DA, James TB, Atkinson LN, Painter JT, Lusardi K. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients. Crit Care Nurse. 2018 Feb; 38(1):24-28. PMID: 29437075.
      View in: PubMed
    51. Gressler LE, Hammond DA, Painter JT. Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. J Pain Palliat Care Pharmacother. 2017 Sep - Dec; 31(3-4):228-236. PMID: 29336654.
      View in: PubMed
    52. Kathe N, Shah A, Said Q, Painter JT. DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study. Diabetes Ther. 2018 Feb; 9(1):141-151. PMID: 29236221.
      View in: PubMed
    53. Hammond DA, Chiu T, Painter JT, Meena N. Nonpharmacist Health Care Providers' Knowledge of and Opinions Regarding Medication Costs in Critically Ill Patients. Hosp Pharm. 2018 Jun; 53(3):188-193. PMID: 30147139.
      View in: PubMed
    54. Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, Chopra D, Meena N. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock. J Intensive Care Med. 2019 Nov-Dec; 34(11-12):910-916. PMID: 28820036.
      View in: PubMed
    55. Hammond DA, Killingsworth CA, Painter JT, Pennick RE, Chatterjee K, Boye B, Meena N. Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults. Pharm Pract (Granada). 2017 Jul-Sep; 15(3):948. PMID: 28943978.
      View in: PubMed
    56. Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC. Comparative Effectiveness of Intra-Articular Hyaluronic Acid and Corticosteroid Injections on the Time to Surgical Knee Procedures. J Arthroplasty. 2017 12; 32(12):3591-3597.e24. PMID: 28781020.
      View in: PubMed
    57. Painter JT, Fortney JC, Austen MA, Pyne JM. Cost-Effectiveness of Telemedicine-Based Collaborative Care for Posttraumatic Stress Disorder. Psychiatr Serv. 2017 Nov 01; 68(11):1157-1163. PMID: 28669290.
      View in: PubMed
    58. Hammond DA, Atkinson LN, James TB, Painter JT, Lusardi K. Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients. Pharm Pract (Granada). 2017 Apr-Jun; 15(2):949. PMID: 28690700.
      View in: PubMed
    59. Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. J Intensive Care Med. 2019 Oct; 34(10):805-810. PMID: 28618919.
      View in: PubMed
    60. Hammond DA, Oyler DR, Devlin JW, Painter JT, Bolesta S, Swanson JM, Bailey BJ, Branan T, Barletta JF, Dunn B, Haney JS, Juang P, Kane-Gill SL, Kiser TH, Shafeeq H, Skaar D, Smithburger P, Taylor J. Perceived Motivating Factors and Barriers for the Completion of Postgraduate Training Among American Pharmacy Students Prior to Beginning Advanced Pharmacy Practice Experiences. Am J Pharm Educ. 2017 Jun; 81(5):90. PMID: 28720918.
      View in: PubMed
    61. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 06; 158(6):1039-1045. PMID: 28195856.
      View in: PubMed
    62. Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC. Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery. J Arthroplasty. 2017 10; 32(10):2952-2957.e21. PMID: 28606459.
      View in: PubMed
    63. Painter JT, Owen R, Henderson KL, Bauer MS, Mittal D, Hudson TJ. Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population. Pharmacotherapy. 2017 Apr; 37(4):438-446. PMID: 28164355.
      View in: PubMed
    64. Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. J Opioid Manag. 2017 Mar/Apr; 13(2):95-103. PMID: 28829524.
      View in: PubMed
    65. Hammond DA, Vines CE, McPhee AL, Bhandari NR, Jones KM, Meena N, Painter JT. Effect of Etomidate on Pneumonia Development in Critically Ill, Nontrauma Patients. J Intensive Care Med. 2019 Jan; 34(1):34-39. PMID: 28027685.
      View in: PubMed
    66. Hammond DA, Hughes CA, Painter JT, Pennick RE, Chatterjee K, Boye B, Meena N. Impact of Targeted Educational Interventions on Clostridium difficile Infection Treatment in Critically Ill Adults. Hosp Pharm. 2016 Dec; 51(11):901-906. PMID: 28057949.
      View in: PubMed
    67. Drummond KL, Painter JT, Curran GM, Stanley R, Gifford AL, Rodriguez-Barradas M, Rimland D, Monson TP, Pyne JM. HIV patient and provider feedback on a telehealth collaborative care for depression intervention. AIDS Care. 2017 03; 29(3):290-298. PMID: 27871183.
      View in: PubMed
    68. Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study. Pharmacotherapy. 2016 05; 36(5):463-71. PMID: 26952639.
      View in: PubMed
    69. Brown JD, Hutchison LC, Li C, Painter JT, Martin BC. Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States. J Am Geriatr Soc. 2016 Jan; 64(1):22-30. PMID: 26782849.
      View in: PubMed
    70. Painter JT, Fortney JC, Gifford AL, Rimland D, Monson T, Rodriguez-Barradas MC, Pyne JM. Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):377-85. PMID: 26102447.
      View in: PubMed
    71. Painter JT, Crofford LJ, Butler JS, Talbert J. Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome. Am J Pharm Benefits. 2014 Nov-Dec; 6(6):e177-e184. PMID: 28553437.
      View in: PubMed
    72. Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. Am J Health Syst Pharm. 2014 Sep 15; 71(18):1539-54. PMID: 25174015.
      View in: PubMed
    73. Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. J Clin Rheumatol. 2013 Mar; 19(2):72-7. PMID: 23364665.
      View in: PubMed
    74. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clin Ther. 2013 Mar; 35(3):303-11. PMID: 23485077.
      View in: PubMed
    75. Painter JT, Fink JL. Educational innovations: Categories of bulletin board postings designed to increase awareness of contemporary pharmaceutical policy issues. Pharm Pract (Granada). 2010 Oct; 8(4):255-9. PMID: 25126150.
      View in: PubMed
    Painter's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (203) concept(s)
    _
    Co-Authors Expand Description
    See all (43) people
    _
    Similar People Expand Description
    See all (32) people
    _
    Same Department Expand Description
    Search Department